Insulet Cash Flow from Investing Activities 2010-2024 | PODD
Insulet annual/quarterly cash flow from investing activities history and growth rate from 2010 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
- Insulet cash flow from investing activities for the quarter ending December 31, 2024 was $-0.146B, a 22.45% increase year-over-year.
- Insulet cash flow from investing activities for the twelve months ending December 31, 2024 was $-0.297B, a 5.47% decline year-over-year.
- Insulet annual cash flow from investing activities for 2024 was $-0.146B, a 22.45% increase from 2023.
- Insulet annual cash flow from investing activities for 2023 was $-0.119B, a 37.52% decline from 2022.
- Insulet annual cash flow from investing activities for 2022 was $-0.191B, a 131.08% increase from 2021.
| Insulet Annual Cash Flow Investing (Millions of US $) |
|
|---|---|
| 2024 | $-146 |
| 2023 | $-119 |
| 2022 | $-191 |
| 2021 | $-83 |
| 2020 | $14 |
| 2019 | $-74 |
| 2018 | $-185 |
| 2017 | $-211 |
| 2016 | $-178 |
| 2015 | $-15 |
| 2014 | $-11 |
| 2013 | $-7 |
| 2012 | $-11 |
| 2011 | $-49 |
| 2010 | $-7 |
| 2009 | $-3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $18.083B | $2.072B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.138B | 28.03 |
| Boston Scientific (BSX) | United States | $152.812B | 38.26 |
| Stryker (SYK) | United States | $145.981B | 30.52 |
| EssilorLuxottica (ESLOY) | France | $128.807B | 0.00 |
| Medtronic (MDT) | Ireland | $107.246B | 15.66 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.937B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.673B | 27.10 |
| ResMed (RMD) | United States | $35.644B | 26.77 |
| GE HealthCare Technologies (GEHC) | United States | $32.281B | 15.33 |
| Agilent Technologies (A) | United States | $30.991B | 20.47 |
| Terumo (TRUMY) | Japan | $28.175B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.624B | 16.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.817B | 12.09 |
| Baxter (BAX) | United States | $16.011B | 11.95 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.408B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.962B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.751B | 22.82 |
| Lantheus Holdings (LNTH) | United States | $5.509B | 14.04 |
| Prestige Consumer Healthcare (PBH) | United States | $4.312B | 19.21 |
| Perrigo (PRGO) | Ireland | $3.684B | 9.34 |
| ICU Medical (ICUI) | United States | $3.516B | 25.93 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.417B | 14.88 |
| Envista Holdings (NVST) | United States | $3.012B | 25.03 |
| QuidelOrtho (QDEL) | United States | $2.459B | 16.96 |
| GN Store Nord (GNNDY) | Denmark | $2.020B | 16.73 |
| LeMaitre Vascular (LMAT) | United States | $1.841B | 41.16 |
| AtriCure (ATRC) | United States | $1.544B | 0.00 |
| Neogen (NEOG) | United States | $1.300B | 16.64 |
| Green Thumb Industries (GTBIF) | United States | $1.234B | 27.76 |
| Kestra Medical Technologies (KMTS) | United States | $1.162B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.130B | 11.47 |
| BioLife Solutions (BLFS) | United States | $1.062B | 0.00 |
| InMode (INMD) | Israel | $0.990B | 9.06 |
| Phibro Animal Health (PAHC) | United States | $0.901B | 11.53 |
| Evolus (EOLS) | United States | $0.651B | 0.00 |
| CeriBell (CBLL) | United States | $0.616B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.592B | 0.00 |
| Owens & Minor (OMI) | United States | $0.540B | 4.48 |
| Valneva SE (VALN) | France | $0.534B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.526B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.445B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.405B | 0.00 |
| Surmodics (SRDX) | United States | $0.389B | 0.00 |
| Omeros (OMER) | United States | $0.368B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.356B | 13.11 |
| SNDL (SNDL) | Canada | $0.344B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.288B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.270B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.267B | 47.50 |
| Verano Holdings (VRNOF) | United States | $0.266B | 0.00 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| ZimVie (ZIMV) | United States | $0.256B | 11.63 |
| Viemed Healthcare (VMD) | United States | $0.254B | 21.40 |
| Canopy Growth (CGC) | Canada | $0.246B | 0.00 |
| Quanterix (QTRX) | United States | $0.214B | 0.00 |
| Biote (BTMD) | United States | $0.205B | 5.75 |
| OraSure Technologies (OSUR) | United States | $0.194B | 0.00 |
| High Tide (HITI) | Canada | $0.193B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.177B | 14.25 |
| TriSalus Life Sciences (TLSI) | United States | $0.167B | 0.00 |
| Brainsway (BWAY) | Israel | $0.167B | 52.18 |
| FitLife Brands (FTLF) | United States | $0.149B | 18.33 |
| Organigram Global (OGI) | Canada | $0.149B | 0.00 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| Exagen (XGN) | United States | $0.111B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
| MacroGenics (MGNX) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.080B | 0.00 |
| Agape ATP (ATPC) | $0.078B | 0.00 | |
| Fonar (FONR) | United States | $0.078B | 10.91 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| United Health Products (UEEC) | United States | $0.058B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Apyx Medical (APYX) | United States | $0.045B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 58.50 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.74 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |